Previous 10 | Next 10 |
Introduction Cannabis is a once-in-a-generation investment opportunity. The chance to invest in an industry in its infancy with so much growth in its future is rare and shouldn't be missed. There are other high-growth industries, but as described below, cannabis offers a constellation of dri...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Greg Marco, President of Leading Edge Expositions, which produces the CWCBExpo ....
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Debra Borchardt . Debra is the CEO, Co-founder, and Editor-in-Chief of t...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Ronan Levy, Chief Strategy Officer at Trait Biosciences, a cannabis biotech firm....
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am excited to be joined by Joe Lusardi, President & CEO of Curaleaf (CURLF), a vertically integrated m...
The FDA has reopened its 30-day comment period related to international drug scheduling on cannabis products. A delay from the World Health Organization disrupted the original schedule. More news on: Cronos Group Inc., Tilray, Inc., Aurora Cannabis Inc., Healthcare stocks news, Consumer ...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by David Sandelman, Chief Engineer at Cannatrol, a precision drying/curing system fo...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by David Brough, CEO of Klonetics Plant Science. He's also President at Precisi...
The broad market's sell-off notwithstanding, cannabis stocks are under pressure after Tilray reported Q2 results after the close yesterday. Revenues were up 371% to $45.9M, albeit from a low base. Investors appear to be reacting to its disclosure that the average price per gram sold droppe...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by Dr. Kyle Kingsley, the founder and CEO of Vireo Health (VREOF), a publicly t...
News, Short Squeeze, Breakout and More Instantly...
AdvisorShares Vice ETF Company Name:
ACT Stock Symbol:
NASDAQ Market:
AdvisorShares Vice ETF Website:
GAAP Net Income of $184 million , or $1.16 per diluted share Adjusted Operating Income of $201 million , or $1.27 per diluted share Return on Equity of 15.4% and Adjusted Operating Return on Equity...
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
RALEIGH, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on July 31, 2024. Enact will host a conference call to review second quarter 2024 financial results on August 1, 2024...